247 related articles for article (PubMed ID: 23974861)
1. Osteoanabolic effect of alendronate and zoledronate on bone marrow stromal cells (BMSCs) isolated from aged female osteoporotic patients and its implications for their mode of action in the treatment of age-related bone loss.
Lindtner RA; Tiaden AN; Genelin K; Ebner HL; Manzl C; Klawitter M; Sitte I; von Rechenberg B; Blauth M; Richards PJ
Osteoporos Int; 2014 Mar; 25(3):1151-61. PubMed ID: 23974861
[TBL] [Abstract][Full Text] [Related]
2. Bisphosphonates induce the osteogenic gene expression in co-cultured human endothelial and mesenchymal stem cells.
Ribeiro V; Garcia M; Oliveira R; Gomes PS; Colaço B; Fernandes MH
J Cell Mol Med; 2014 Jan; 18(1):27-37. PubMed ID: 24373581
[TBL] [Abstract][Full Text] [Related]
3. Alendronate enhances osteogenic differentiation of bone marrow stromal cells: a preliminary study.
Kim HK; Kim JH; Abbas AA; Yoon TR
Clin Orthop Relat Res; 2009 Dec; 467(12):3121-8. PubMed ID: 18665432
[TBL] [Abstract][Full Text] [Related]
4. Enhanced Osteogenic Differentiation in Zoledronate-Treated Osteoporotic Patients.
Dalle Carbonare L; Mottes M; Malerba G; Mori A; Zaninotto M; Plebani M; Dellantonio A; Valenti MT
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28608802
[TBL] [Abstract][Full Text] [Related]
5. Positive Effects of Bisphosphonates on Osteogenic Differentiation in Patient-Derived Mesenchymal Stem Cells for the Treatment of Osteoporosis.
Cha M; Lee KM; Lee JH
Tissue Eng Regen Med; 2018 Aug; 15(4):467-475. PubMed ID: 30603570
[TBL] [Abstract][Full Text] [Related]
6. Pulse treatment with zoledronic acid causes sustained commitment of bone marrow derived mesenchymal stem cells for osteogenic differentiation.
Ebert R; Zeck S; Krug R; Meissner-Weigl J; Schneider D; Seefried L; Eulert J; Jakob F
Bone; 2009 May; 44(5):858-64. PubMed ID: 19442618
[TBL] [Abstract][Full Text] [Related]
7. The susceptive alendronate-treatment timing and dosage for osteogenesis enhancement in human bone marrow-derived stem cells.
Chang CH; Wang CZ; Chang JK; Hsu CY; Ho ML
PLoS One; 2014; 9(8):e105705. PubMed ID: 25157615
[TBL] [Abstract][Full Text] [Related]
8. Effects of Intermittent Parathyroid Hormone 1-34 Administration on Circulating Mesenchymal Stem Cells in Postmenopausal Osteoporotic Women.
Tang Y; Xia H; Kang L; Sun Q; Su Z; Hao C; Xue Y
Med Sci Monit; 2019 Jan; 25():259-268. PubMed ID: 30620727
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of osteoblast function in vitro by aminobisphosphonates.
Orriss IR; Key ML; Colston KW; Arnett TR
J Cell Biochem; 2009 Jan; 106(1):109-18. PubMed ID: 19003973
[TBL] [Abstract][Full Text] [Related]
10. Novel daidzein analogs enhance osteogenic activity of bone marrow-derived mesenchymal stem cells and adipose-derived stromal/stem cells through estrogen receptor dependent and independent mechanisms.
Strong AL; Ohlstein JF; Jiang Q; Zhang Q; Zheng S; Boue SM; Elliott S; Gimble JM; Burow ME; Wang G; Bunnell BA
Stem Cell Res Ther; 2014 Aug; 5(4):105. PubMed ID: 25168698
[TBL] [Abstract][Full Text] [Related]
11. The effect of nitrogen containing bisphosphonates, zoledronate and alendronate, on the production of pro-angiogenic factors by osteoblastic cells.
Ishtiaq S; Edwards S; Sankaralingam A; Evans BA; Elford C; Frost ML; Fogelman I; Hampson G
Cytokine; 2015 Feb; 71(2):154-60. PubMed ID: 25461393
[TBL] [Abstract][Full Text] [Related]
12. 5'-hydroxy Auraptene stimulates osteoblast differentiation of bone marrow-derived mesenchymal stem cells via a BMP-dependent mechanism.
Abdallah BM; Ali EM
J Biomed Sci; 2019 Jul; 26(1):51. PubMed ID: 31277646
[TBL] [Abstract][Full Text] [Related]
13. Panax notoginseng saponins promotes proliferation and osteogenic differentiation of rat bone marrow stromal cells.
Li XD; Wang JS; Chang B; Chen B; Guo C; Hou GQ; Huang DY; Du SX
J Ethnopharmacol; 2011 Mar; 134(2):268-74. PubMed ID: 21167926
[TBL] [Abstract][Full Text] [Related]
14. Silencing of Long Non-Coding RNA NONHSAT009968 Ameliorates the Staphylococcal Protein A-Inhibited Osteogenic Differentiation in Human Bone Mesenchymal Stem Cells.
Cui Y; Lu S; Tan H; Li J; Zhu M; Xu Y
Cell Physiol Biochem; 2016; 39(4):1347-59. PubMed ID: 27607236
[TBL] [Abstract][Full Text] [Related]
15. Aminobisphosphonates cause osteoblast apoptosis and inhibit bone nodule formation in vitro.
Idris AI; Rojas J; Greig IR; Van't Hof RJ; Ralston SH
Calcif Tissue Int; 2008 Mar; 82(3):191-201. PubMed ID: 18259679
[TBL] [Abstract][Full Text] [Related]
16. Symphytum officinale augments osteogenesis in human bone marrow-derived mesenchymal stem cells in vitro as they differentiate into osteoblasts.
Dey D; Jingar P; Agrawal S; Shrivastava V; Bhattacharya A; Manhas J; Garg B; Ansari MT; Mridha AR; Sreenivas V; Khurana A; Sen S
J Ethnopharmacol; 2020 Feb; 248():112329. PubMed ID: 31672526
[TBL] [Abstract][Full Text] [Related]
17. Randomized trial comparing efficacies of zoledronate and alendronate for improving bone mineral density and inhibiting bone remodelling in women with post-menopausal osteoporosis.
Tan W; Sun J; Zhou L; Li Y; Wu X
J Clin Pharm Ther; 2016 Oct; 41(5):519-23. PubMed ID: 27440710
[TBL] [Abstract][Full Text] [Related]
18. Synergistic effect of recombinant human bone morphogenic protein-7 and osteogenic differentiation medium on human bone-marrow-derived mesenchymal stem cells in vitro.
Zhi L; Chen C; Pang X; Uludag H; Jiang H
Int Orthop; 2011 Dec; 35(12):1889-95. PubMed ID: 21487672
[TBL] [Abstract][Full Text] [Related]
19. KR‑12‑a6 promotes the osteogenic differentiation of human bone marrow mesenchymal stem cells via BMP/SMAD signaling.
Fu L; Jin P; Hu Y; Lu H; Su L
Mol Med Rep; 2020 Jan; 21(1):61-68. PubMed ID: 31939626
[TBL] [Abstract][Full Text] [Related]
20. Vertebral Bone Marrow-Derived Mesenchymal Stromal Cells from Osteoporotic and Healthy Patients Possess Similar Differentiation Properties In Vitro.
Haddouti EM; Randau TM; Hilgers C; Masson W; Pflugmacher R; Burger C; Gravius S; Schildberg FA
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33167522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
